Eyebright Medical Technology (Beijing) Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000041J5
CNY
61.28
0.57 (0.94%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,395.87
936.19
570.81
425.90
269.06
191.95
124.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,395.87
936.19
570.81
425.90
269.06
191.95
124.90
Raw Material Cost
532.46
266.83
114.95
87.73
59.22
39.86
29.67
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
290.25
200.60
120.90
106.39
62.08
52.28
58.94
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
20.96
9.98
2.12
0.83
0.06
0.22
1.68
Selling and Distribution Expenses
338.08
281.37
169.13
136.35
88.43
74.57
66.82
Other Expenses
-22.03
-13.13
-6.87
-6.41
-3.88
-3.67
-5.04
Total Expenditure (Excl Depreciation)
961.43
627.48
338.38
267.22
170.97
130.26
106.70
Operating Profit (PBDIT) excl Other Income
434.4
308.7
232.39999999999998
158.7
98.10000000000001
61.7
18.2
Other Income
28.14
31.13
33.26
30.78
13.93
11.51
10.02
Operating Profit (PBDIT)
601.78
425.72
317.03
227.98
141.22
96.70
31.76
Interest
20.96
9.98
2.12
0.83
0.06
0.22
1.68
Exceptional Items
-4.23
-1.84
1.49
0.20
0.28
-2.65
2.65
Gross Profit (PBDT)
863.41
669.37
455.86
338.17
209.83
152.10
95.22
Depreciation
145.59
86.46
52.43
39.37
30.26
24.16
6.02
Profit Before Tax
431.00
327.44
263.97
187.99
111.18
69.66
26.71
Tax
44.02
41.62
36.85
20.01
14.92
3.90
6.41
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
388.40
303.98
232.69
171.34
96.56
66.69
20.31
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
388.40
303.98
232.69
171.34
96.56
66.69
20.31
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.32
-17.93
-5.46
-3.59
-0.44
-0.93
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
387.08
286.05
227.23
167.75
96.12
65.76
20.31
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,409.50
2,129.63
1,860.19
1,673.85
1,518.10
617.56
550.87
Earnings per share (EPS)
2.05
1.6
1.23
0.91
0.51
0.35
0.11
Diluted Earnings per share
2.05
1.6
1.23
0.91
0.51
0.35
0.11
Operating Profit Margin (Excl OI)
30.67%
32.91%
40.53%
37.06%
36.06%
31.79%
12.59%
Gross Profit Margin
41.31%
44.21%
55.43%
53.38%
52.57%
48.88%
26.21%
PAT Margin
27.83%
32.47%
40.77%
40.23%
35.89%
34.74%
16.26%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 49.10% vs 64.02% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 35.30% vs 25.92% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 45.36% vs 39.04% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 110.00% vs 376.19% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Eyebright Medical Technology (Beijing) Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,395.87
0
1,395.87
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,395.87
0
1,395.87
Raw Material Cost
532.46
0
532.46
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
290.25
0
290.25
Power Cost
0
0
0.00
Manufacturing Expenses
20.96
0
20.96
Selling and Distribution Expenses
338.08
0
338.08
Other Expenses
-22.03
0.00
-22.03
Total Expenditure (Excl Depreciation)
961.43
0
961.43
Operating Profit (PBDIT) excl Other Income
434.44
0.00
434.44
Other Income
28.14
0
28.14
Operating Profit (PBDIT)
601.78
0
601.78
Interest
20.96
0
20.96
Exceptional Items
-4.23
0
-4.23
Gross Profit (PBDT)
863.41
0
863.41
Depreciation
145.59
0
145.59
Profit Before Tax
431.00
0
431.00
Tax
44.02
0
44.02
Provisions and contingencies
0
0
0.00
Profit After Tax
388.40
0
388.40
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
388.40
0
388.40
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.32
0
-1.32
Other related items
0.00
0.00
0.00
Consolidated Net Profit
387.08
0
387.08
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,409.50
0
2,409.50
Earnings per share (EPS)
2.05
0
2.05
Diluted Earnings per share
2.05
0
2.05
Operating Profit Margin (Excl OI)
30.67%
0%
0.00
30.67%
Gross Profit Margin
41.31%
0%
0.00
41.31%
PAT Margin
27.83%
0%
0.00
27.83%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 139.59 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 49.10% vs 64.02% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 38.71 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 35.30% vs 25.92% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 57.36 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 45.36% vs 39.04% in Dec 2023

Annual - Interest
Interest 2.10 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 110.00% vs 376.19% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.67%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023